Priming CLL cells with CXCR4 blocking antibodies or the addition of blocking antibodies against IL-10 to the coculture of CXCL12-treated CLL and T cells completely reversed T cell dysfunction (Figures 3 and 4). The gene discussed is CXCL12; the disease is B-cell chronic lymphocytic leukemia.